MOB Stock Splits - Moberg Pharma AB (publ)

Price: 7.075 SEK -1.8%

Market Cap: 338.8m SEK

The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.

Before the split, MOB traded at 12 per share. Afterward, the share price was about 9.95.

The adjusted shares began trading on Aug 11, 2023. This was MOB's 4th stock split, following the previous one in May 24, 2023.

Aug 11, 2023

3-for-2

May 24, 2023

1-for-10

May 10, 2022

697-for-673

Dec 2, 2020

1098-for-971

Pre-Split Price

Post-Split Price

9.95

Adjust Price

Aug 11, 2023

3-for-2

May 24, 2023

1-for-10

May 10, 2022

697-for-673

Dec 2, 2020

1098-for-971

Moberg Pharma AB (publ)
Stock Splits History

Logarithmic

Aug 11, 2023

Split 3-for-2

x1.5

Pre-Split Price

Post-Split Price

9.95

Adjust Price

May 24, 2023

Split 1-for-10

/0.1

Pre-Split Price

Post-Split Price

14.6733

Adjust Price

May 10, 2022

Split 697-for-673

x1.035661218425

Pre-Split Price

15.8353

Post-Split Price

15.8667

Adjust Price

Dec 2, 2020

Split 1098-for-971

x1.1307929969104

Pre-Split Price

40.6844

Post-Split Price

39.6687

Adjust Price

Global
Stock Splits Monitor

Forward Splits

Reverse Splits

Adjust Price

Date	Company		Split	Pre-Split Price	Post-Split Price
Apr 7, 2025		BioNexus Gene Lab Corp NASDAQ:BGLC BGLC Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-10 /10	0.235 2.35 USD	2.92 2.92 USD
Apr 7, 2025		Alligator Bioscience AB STO:ATORX ATORX Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-1000 /1000	0.0055 5.5 SEK	5.4 5.4 SEK
Apr 7, 2025		Treasure Global Inc NASDAQ:TGL TGL Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-50 /50	0.057 2.85 USD	2.8 2.8 USD
Apr 7, 2025	S	Safe & Green Development Corp NASDAQ:SGD SGD Valuation & Fundamental Analysis Stock Splits Performance Benchmark	105-for-100 x1.05	1.28 1.219 USD	1.14 1.14 USD
Apr 7, 2025	G	Ge-Shen Corporation Bhd KLSE:GESHEN GESHEN Valuation & Fundamental Analysis Stock Splits Performance Benchmark	959692-for-319897 x3.0000031260062	4.35 1.45 MYR	1.37 1.37 MYR

Moberg Pharma AB (publ)
Glance View

Market Cap

330.4m SEK

Industry

Pharmaceuticals

Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. The company is headquartered in Bromma, Stockholm. The company went IPO on 2011-05-26. Its product portfolio includes products for the treatment of skin diseases and pain, such as Emtrix/Nalox, for the treatment of nails damaged by fungus or psoriasis; Kerasal, for dry and damaged feet, and Kaprolac, a range of products for several types of skin and scalp problems. Additionally, the Company has two projects in phase II of development, namely MOB-15, for the treatment of nail fungus, and Limtop, for the treatment of actinic keratosis, basalioma and genital warts. The firm collaborates with Meda AB, Menarini Group, Perrigo Company, OzHealth Pharma and Zelmic AB, among others. The company is active in more than 35 countries, and operates, among others, through Alterna LLC. The company also owns three Over-The-Counter (OTC) brands in the United States.

View MOB Analysis

MOB Intrinsic Value

Show

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

	ABM Industries Inc NYSE:ABM	46.11 USD 3.92%
	Silicon Motion Technology Corp NASDAQ:SIMO	40.45 USD 2.09%
	A-Mark Precious Metals Inc NASDAQ:AMRK	23.82 USD 7.71%
	Fox Factory Holding Corp NASDAQ:FOXF	19.81 USD -0.35%
	Ferrexpo PLC LSE:FXPO	50.7625 GBX 5.21%
	Jet2 PLC LSE:JET2	1 299 GBX 3.59%

	Franklin Covey Co NYSE:FC	20.21 USD 2.9%
	Mohawk Industries Inc NYSE:MHK	105.05 USD 1.97%
	Ardmore Shipping Corp NYSE:ASC	9.29 USD 6.17%
	ASGN Inc NYSE:ASGN	60.13 USD 1.35%
	Skyworks Solutions Inc NASDAQ:SWKS	56.54 USD 5.01%
	Weatherford International PLC NASDAQ:WFRD	43 USD 7.18%

	Johnson & Johnson NYSE:JNJ	151.73 USD 2.04%
	Bank of America Corp NYSE:BAC	35.95 USD 0.28%
	Mastercard Inc NYSE:MA	509.75 USD 2.08%
	Salesforce Inc NYSE:CRM	255 USD -0.05%
	Abbvie Inc NYSE:ABBV	175.05 USD 0.49%
	Home Depot Inc NYSE:HD	353.86 USD 0.07%

Moberg Pharma AB (publ)
STO:MOB

MOB's latest stock split occurred on Aug 11, 2023

Moberg Pharma AB (publ)
Stock Splits History

Global
Stock Splits Monitor

Moberg Pharma AB (publ)
Glance View

Company

Help

Tools

Stocks

	Arista Networks Inc NYSE:ANET	72.67 USD 0.03%
	Visa Inc NYSE:V	333.4 USD 2.71%
	Texas Pacific Land Corp NYSE:TPL	1 236.1 USD 4.17%
	KLA Corp NASDAQ:KLAC	670.22 USD 2.05%
	Manhattan Associates Inc NASDAQ:MANH	158.67 USD 0.65%
	Monolithic Power Systems Inc NASDAQ:MPWR	533.13 USD 9.99%

	ServiceNow Inc NYSE:NOW	785.67 USD 0.28%
	EOG Resources Inc NYSE:EOG	108.54 USD 3.76%
	Monster Beverage Corp NASDAQ:MNST	58.15 USD 0.66%
	Copart Inc NASDAQ:CPRT	59.84 USD 2.01%
	Applied Materials Inc NASDAQ:AMAT	144.94 USD 4.85%
	Airbnb Inc NASDAQ:ABNB	114.54 USD 0.55%

52 Week Range	6.96 38.92
Price Target

Moberg Pharma AB (publ) STO:MOB

MOB's latest stock split occurred on Aug 11, 2023

Moberg Pharma AB (publ) Stock Splits History

Global Stock Splits Monitor

Moberg Pharma AB (publ) Glance View

Company

Help

Tools

Stocks

Moberg Pharma AB (publ)
STO:MOB

Moberg Pharma AB (publ)
Stock Splits History

Global
Stock Splits Monitor

Moberg Pharma AB (publ)
Glance View